Search
Watson Pharmaceutical: Acquires Drug Production License and GMP Compliance for Two Products
1 week ago /
Read about 0 minute
Author：小编
Watson Pharmaceutical has successfully secured a Drug Production License from the Chongqing Medical Products Administration, along with a GMP Compliance Inspection Notification for two of its products. The company has been newly entrusted with the production of esomeprazole sodium for injection, and its corresponding production line has successfully passed the stringent GMP inspection. This strategic move aims to optimize capacity utilization and facilitate large-scale production, ultimately enhancing operational efficiency. However, it is anticipated that this change will have a modest impact on the company's short-term performance.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
